#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15948	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2497	781.6	0	.	n	.	0	A69G	SNP	69	69	A	624	624	G	969	G,A	968,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15948	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2497	781.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	2005	2005	T	1037	T,A	1036,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15948	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2497	781.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1739	1739	C	1065	C,T,A	1063,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15948	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2497	781.6	0	HET	.	.	.	C260T	.	260	260	C	815	815	C	957	C,T	776,181	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27360	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3999	853.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1926	1926	A	1094	A,G	1092,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27360	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3999	853.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2560	2560	C	961	C	961	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27360	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3999	853.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2634	2634	A	947	A,C	945,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27360	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3999	853.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3186	3186	C	966	C,G	965,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2346	folP	855	855	99.88	folP.l15.c4.ctg.1	1966	148.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1205	1207	AGC	242;241;242	A;G;C	242;241;242	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5916	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3944	187.2	1	SNP	p	S91F	0	.	.	271	273	TCC	877	879	TCC	187;186;184	T;C;C	187;186;184	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5916	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3944	187.2	1	SNP	p	D95G	0	.	.	283	285	GAC	889	891	GAC	199;200;200	G;A;C	199;200;200	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5916	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3944	187.2	1	SNP	p	D95N	0	.	.	283	285	GAC	889	891	GAC	199;200;200	G;A;C	199;200;200	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	2228	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	2037	136.7	0	.	p	.	0	S32W	NONSYN	94	96	TCG	785	787	TGG	235;234;234	T,G;G;G	234,1;234;234	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	2228	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	2037	136.7	0	.	p	.	0	D79N	NONSYN	235	237	GAT	926	928	AAT	249;249;250	A;A;T	249;249;250	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	2228	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	2037	136.7	1	SNP	p	G45D	0	.	.	133	135	GGC	824	826	GGC	239;240;241	G,C;G;C	238,1;240;241	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1246	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1637	95.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3562	192.4	1	SNP	p	D86N	0	.	.	256	258	GAC	948	950	GAC	244;242;242	G,C;A,G,C;C,A	243,1;240,1,1;241,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3562	192.4	1	SNP	p	S87I	0	.	.	259	261	AGT	951	953	AGT	241;240;241	A,G,C;G;T,C	239,1,1;240;240,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3562	192.4	1	SNP	p	S87R	0	.	.	259	261	AGT	951	953	AGT	241;240;241	A,G,C;G;T,C	239,1,1;240;240,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3562	192.4	1	SNP	p	S87W	0	.	.	259	261	AGT	951	953	AGT	241;240;241	A,G,C;G;T,C	239,1,1;240;240,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3562	192.4	1	SNP	p	S88P	0	.	.	262	264	TCC	954	956	TCC	244;245;243	T,C;C,A;C,T	243,1;244,1;242,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4882	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3200	190.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1774	1776	GGC	236;233;232	G,A;G,A;C	235,1;232,1;232	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1526	1528	GCA	263;260;260	G;C;A	263;260;260	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1529	1531	ATC	258;257;259	A;T;C,T	258;257;258,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1541	1543	GTG	254;260;253	G;T;G,T	254;260;252,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1541	1543	GTG	254;260;253	G;T;G,T	254;260;252,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2045	2047	ACC	228;226;227	A;C;C,T	228;226;226,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2099	2101	GCG	210;212;212	G;C;G	210;212;212	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2099	2101	GCG	210;212;212	G;C;G	210;212;212	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2222	2224	GGC	257;258;255	G;G;C	257;258;255	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2231	2233	GGC	247;247;249	G;G,C;C	247;246,1;249	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4428	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2973	186.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2249	2251	CTG	250;253;250	C;T;G	250;253;250	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6386	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3609	220.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1929	1931	CCG	292;292;296	C,G;C,T;G,A	291,1;291,1;294,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2632	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2308	142.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	841	841	C	195	C	195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	G38E	NONSYN	112	114	GGA	609	611	GAA	274;272;270	G;A;A	274;272;270	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	S46G	NONSYN	136	138	AGC	633	635	GGC	284;282;284	G,C;G;C,T,A	283,1;282;282,1,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	T87A	NONSYN	259	261	ACT	756	758	GCT	271;272;270	G;C;T	271;272;270	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	762	764	AGC	271;269;265	A;G;C,T	271;269;264,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	924	926	CAA	258;260;260	C;A;A,G	258;260;259,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1140	1142	ACT	284;281;281	A;C,G;T,A	284;280,1;280,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	S220T	NONSYN	658	660	AGT	1155	1157	ACT	269;269;266	A;C;T	269;269;266	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	G255R	NONSYN	763	765	GGA	1260	1262	AGA	273;280;279	A;G;A	273;280;279	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1263	1265	GCA	279;277;275	G,C;C,G;A	278,1;276,1;275	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	W257M	NONSYN	769	771	TGG	1266	1268	ATG	277;279;281	A,T;T;G	276,1;279;281	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1272	1274	GGT	286;285;287	G;G;T	286;285;287	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	3212	porB1b	1047	1047	97.52	porB1b.l15.c4.ctg.1	1937	206.2	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1332	1334	GTA	261;262;262	G;T;A	261;262;262	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11150	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5478	254.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2303	2305	CAT	303;297;299	C;A,G;T	303;296,1;299	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1758	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1593	137.7	1	SNP	p	V57M	1	.	.	169	171	ATG	797	799	ATG	332;333;336	A;T,C;G	332;332,1;336	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
